Diabetic ulcers with an experimental dose schedule · Randomized trial · 2013
Does adding shockwave help diabetic leg and foot ulcers shrink?
In this trial, wounds shrank in both groups over 12 weeks: from about 9 to 2 cm² with three shockwave sessions, one a week, added to wound care, and from about 8 to 5 cm² with wound care alone.
- adults with diabetic leg or foot ulcers
- 40
- shockwave sessions, one a week
- 3
- weeks of follow-up
- 12
Good to know: Some of the paper's graphs and statistics don't match its tables.
Adel A. Nossair; Marwa M. Eid; Amr B. Salama Journal of American Science, 2013 · Read the paper ↗
How this study worked
What happened
Wound size
Wound area in cm² · start and after 12 weeks
StartAfter 12 weeks
Show the numbers
| Group | People | Start | After 12 weeks |
|---|---|---|---|
| Shockwave + wound care | 20 | 8.86 | 1.92 |
| Wound care alone | 20 | 8.32 | 4.65 |
The treatment
Shockwave + wound care
Unfocused, once a week for 3 weeks
- Sessions
- 3, one a week
- Pulses
- 500 per area · each cm² of wound
- Strength
- 0.1mJ/mm² as reported in the paper
- Numbing
- Not mentioned
- Device
- BTL-5000 SWT Power
- Everyone also got
- Usual medical and wound care: wound cleaning, pressure relief and infection treatment
Compared with: The same medical and wound care without shockwave
Settings are what each study used, not a prescription.
Who took part
40 adults aged 40–70 with diabetic leg or foot ulcers present for at least 3 months, without poor blood flow; 20 per group, all finished.
Side effects
The study does not report side effects.
All the numbers and the full appraisal
The results, in numbers.
40 adults aged 40–70 with diabetic lower-limb ulcers ≥3 months, 1–20 cm², grade 2/3; 20 per group, all completed. Vascular insufficiency excluded.
Participant counts; outcome-specific denominators remain in each panel.
Participant counts; outcome-specific denominators remain in each panel.
Residual wound area1 reported outcome
Residual wound area
Residual wound area cm²
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Shockwave treatment | 20 | 8.86 (SD 3.41) | 1.92 (SD 3.28) |
| Control | 20 | 8.32 (SD 3.88) | 4.65 (SD 3.43) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Table means preserved; incompatible graph and t/p reporting prevent confident inference.
Analysis details and source
Table means preserved; incompatible graph and t/p reporting prevent confident inference.
Reported epithelialization percentage1 reported outcome
Reported epithelialization percentage
Reported epithelialization percentage % wound area
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Shockwave treatment | 20 | — | 83.26 (SD 27.43) |
| Control | 20 | — | 48.66 (SD 31.68) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Mean percentage of wound area healed, not proportion of people completely healed.
Analysis details and source
Mean percentage of wound area healed, not proportion of people completely healed.
How treatment was delivered
BTL-5000 SWT Power, called unfocused; 500 pulses/cm², 0.1 mJ/mm², three weekly sessions; sterile gel/drape and moving head over wound/edges. Frequency/anesthesia not stated; device-energy correspondence unresolved.
Patients were asked to report side effects, but no adverse-event count or structured safety results are supplied. Safety claims are therefore weakly supported.
Randomization method, concealment and assessor blinding unreported. Table 1 t=2.57 with p=.0001 is internally questionable; prose says p<.01. Figure 1 prints 5.92 instead of table 1.92 and chart labels conflict; Figure 2 labels reverse values. Use Table 1 descriptively without accepting exact significance. No funding/conflict statement located.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- Randomization method, concealment and assessor blinding unreported. Table 1 t=2.57 with p=.0001 is internally questionable; prose says p<.01. Figure 1 prints 5.92 instead of table 1.92 and chart labels conflict; Figure 2 labels reverse values. Use Table 1 descriptively without accepting exact significance. No funding/conflict statement located.
Source-linked critical reading
Randomized trials
Technical source record
Full source read: body, methods, results, all tables and figure captions, discussion and references. The paper has no funding or conflict-of-interest statement and cites no supplementary material.
The paper reports smaller wounds, but inconsistent graphs and statistics make the result uncertain.
Does adding shockwaves to wound care reduce area and increase epithelialization of nonvascular diabetic lower-limb ulcers?
Trial reporting random assignment of 40 adults, 20 per group, to shockwaves plus wound care or wound care alone, assessed after 12 weeks.
40 adults aged 40–70 with diabetic lower-limb ulcers ≥3 months, 1–20 cm², grade 2/3; 20 per group, all completed. Vascular insufficiency excluded.
Three weekly shockwave sessions in addition to usual medical/wound care.
Medical treatment, debridement, pressure relief and infection treatment alone.
Wound area was measured by planimetry, averaging three tracings at baseline and 12 weeks. The authors calculated the percentage of epithelialization from change in area; this is not a count of completely healed patients.
Table 1 wound area decreased 8.86±3.41 to 1.92±3.28 cm² with ESWT and 8.32±3.88 to 4.65±3.43 with control. Reported epithelialization percentages 83.26±27.43 versus 48.66±31.68 at 12 weeks.
Patients were asked to report side effects, but no adverse-event count or structured safety results are supplied. Safety claims are therefore weakly supported.
Randomization method, concealment and assessor blinding unreported. Table 1 t=2.57 with p=.0001 is internally questionable; prose says p<.01. Figure 1 prints 5.92 instead of table 1.92 and chart labels conflict; Figure 2 labels reverse values. Use Table 1 descriptively without accepting exact significance. No funding/conflict statement located.
Small selected sample and source inconsistencies limit confidence. The BTL device is called unfocused in the paper; physical modality and energy reporting need verification.
A registered trial should clarify allocation and device settings, publish consistent wound-area tables and figures, and record complete closure, infection and treatment-related adverse events.
Read the original article.
Advanced Protocol of Shock Wave Therapy for Diabetic Foot Ulcer
Adel A. Nossair; Marwa M. Eid; Amr B. Salama · Journal of American Science · 2013
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →